Posted by M.Popov on 12th Nov 2020
Antibodies and ELISA kits related to nCoV-2019 novel coronavirus research
Antibodies and ELISA kits related to nCoV-2019 novel coronavirus research
Abstract
- History of coronaviruses
- Recent research of the 2019-nCoV
- Antibodies and ELISA kits to support coronavirus research
History of coronaviruses
Coronaviruses are first described in detail back in the 1960s, receiving their name from the distinctive shape of the sugary- proteins spiking from the envelope that surround the particle, resembling a crown. They possess the longest genome of any RNA- based virus: one strand of nucleic acid long between 26,000 to 32,000 bases. SARS-CoV-2, known previously as 2019- nCoV, is the latest strand of this family to be discovered. It possesses similar symptoms as the Middle Eastern respiratory syndrome coronavirus (MERS-CoV) and the severe acute respiratory syndrome coronavirus (SARS-CoV). This new strand of coronavirus can cause flu- like symptoms in humans which can lead to severe acute respiratory syndrome, pneumonia and in some cases death.
Recent research of the 2019-nCoV
Since the initial outbreak in Wuhan, China, scientists focused on identifying the sequence of this particular strand. Chinese researchers found that the novel coronavirus is part of the 2B group, with at least 70% similarity to SARS-CoV and over 90% with a bat coronavirus.
Invading host cells happens by the virus attaching a specific cellular receptor via the spike protein. SARS-CoV uses the ACE-2 receptor, while MERS-CoV binds to DPP4. The results of recent studies show that the new strand of coronavirus can use the same receptor/ ACE-2/ to enter the cell as its predecessor, the SARS- CoV.
Up to the time of publishing this article, no vaccines or antiviral treatment have been created for the new strand of coronavirus. Currently the main focus is on agents targeting cell components and specifically host cell receptors in order to minimise and block viral replication.
We offer antibodies and ELISA kits suitable for research purposes of the new strand of Coronavirus.
Antibodies and ELISA kits to support coronavirus research
Coronavirus related antibodies
Model | Name | Application | |
STJ140102 | Anti-MERSC-CoV Spike Protein antibody | WB | Trial size |
STJ400091 | Anti-CoV OC43 antibody | ELISA | |
STJ400092 | Anti-CoV OC43 antibody | ELISA | |
STJ98377 | Anti-SARS-E2 antibody | WB, ELISA | |
STJ98378 | Anti-SARS-M antibody | WB, ELISA |
ACE-2 receptor antibodies
Cytokine antibodies
Model | Name | Application | |
STJ113176 | Anti-TNF Antibody | WB | |
STJ114324 | Anti-IFNG Antibody | WB | |
STJ116437 | Anti-IFNGR2 Antibody | WB | |
STJ140123 | Anti-TNF alpha antibody | WB | |
STJ193179 | Anti-IL17RA Antibody | IHC,WB | Trial size |
STJ23298 | Anti-CXCL10 Antibody | WB | |
STJ24133 | Anti-IFNG Antibody | WB,IHC | |
STJ24134 | Anti-IFNGR2 Antibody | WB,IHC,FC | |
STJ25882 | Anti-TNF Antibody | WB,IHC,IF | |
STJ28315 | Anti-IFNGR1 Antibody | WB | |
STJ29696 | Anti-IFNGR2 Antibody | WB | |
STJ29854 | Anti-DPP4 Antibody | WB | |
STJ71202 | Anti-DPP4 Antibody | Pep-ELISA, WB | |
STJ73001 | Anti-IFNGR1 Antibody | Pep-ELISA, WB | |
STJ90529 | Anti-Phospho-IL-2 beta (Y364) antibody | WB,IF,ELISA | Trial size |
STJ90530 | Anti-Phospho-IL-2 beta (Y364) antibody | WB,ELISA | Trial size |
STJ90719 | Anti-Phospho-IL-2 alpha (S268) antibody | WB,IHC,IF,ELISA | Trial size |
STJ93682 | Anti-IL-17RC antibody | WB,ELISA | Trial size |
STJ93683 | Anti-IL-17 alpha antibody | WB,ELISA | Trial size |
STJ93688 | Anti-IL-2 antibody | WB,ELISA | Trial size |
STJ93693 | Anti-IL-2 alpha antibody | WB,IF,ELISA | Trial size |
STJ93694 | Anti-IL-2 beta antibody | WB,ELISA | Trial size |
STJ93695 | Anti-IL-2 beta antibody | WB,IHC,ELISA | Trial size |
STJ93696 | Anti-IL-2 beta antibody | WB,IF,ELISA | Trial size |
STJ93744 | Anti-IP-10 antibody | IHC,ELISA | Trial size |
STJ96054 | Anti-TNF-alpha antibody | IF,ELISA | Trial size |
STJ96516 | Anti-TNF-alpha antibody | ELISA,IHC,WB | Trial size |
STJ96608 | Anti-IL-2 alpha antibody | WB,ELISA | Trial size |
STJ96629 | Anti-IL-2 beta antibody | WB,ELISA | Trial size |
STJ97488 | Anti-TNF alpha antibody | WB | Trial size |
STJ97489 | Anti-TNF alpha antibody | WB,IHC | Trial size |
STJ97493 | Anti-TNF alpha antibody | IHC,WB | Trial size |
STJ97494 | Anti-TNF alpha antibody | IHC,WB | Trial size |
STJ97660 | Anti-CD26 antibody | WB,IHC,ELISA | Trial size |
STJ98172 | Anti-IL-2 antibody | WB,ELISA | Trial size |
STJ99202 | Anti-TNF-a antibody | WB,ELISA | Trial size |
ELISA kits
Model | Name |
STJ150067 | Rat IL6 Elisa kit |
STJ150068 | Rat CXCL10 ELISA kit |
STJ150070 | Rat IL17A ELISA kit |
STJ150102 | Human IL6 ELISA kit |
STJ150104 | Human IL-2 (Interleukin 2) ELISA kit |
STJ150106 | Human IL6 ELISA kit |
STJ150108 | Human IL17A ELISA kit |
STJ150109 | Human IFN-gamma(Interferon Gamma) ELISA kit |
STJ150110 | Human TNF ELISA kit |
STJ150112 | Human VEGFA ELISA kit |
STJ150117 | Human IL1B ELISA kit |
STJ150153 | Mouse IL6 ELISA kit |
STJ150154 | Mouse IL1B ELISA kit |
STJ150156 | Mouse IL6 ELISA kit |
STJ150157 | Mouse TNF ELISA kit |
STJ150169 | Rat IFN-gamma(Interferon Gamma) ELISA kit |
STJ150171 | Rat IL1B ELISA kit |
STJ150172 | Rat IL6 ELISA kit |
STJ150174 | Rat TNF ELISA kit |
STJ150221 | Mouse IFN-gamma(Interferon Gamma) ELISA kit |
STJ150226 | Mouse IL-2(Interleukin 2) ELISA kit |
STJ150228 | Mouse CXCL10 ELISA kit |
STJ150234 | Mouse VEGFA ELISA kit |
STJ150236 | Rat IL-2(Interleukin 2) ELISA kit |
STJ150239 | Rat VEGFA ELISA kit |
STJ150545 | Mouse IL6ST ELISA kit |
STJ150546 | Mouse IL6R ELISA kit |
- For further information on the outbreak please visit: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
References
- https://www.ncbi.nlm.nih.gov/books/NBK7782/
- https://pubs.rsna.org/doi/pdf/10.1148/radiol.2020200274
- http://virological.org/t/novel-2019-coronavirus-genome/319/2
- https://www.ncbi.nlm.nih.gov/books/NBK92477/